Neuromodulation - Boston Scientific
Cognita Care provides personalized support services and innovative tools to help Boston Scientific pain patients find and maintain effective, long-term relief. Learn more about the Cognita Care The Vertiflex™ Procedure†
Neuromodulation - Boston Scientific
Boston Scientific G4™ generator is designed to give consistent results with a wide range of features in an easy-to-use interface. Ability to treat up to four sites at once with independently controlled electrode outputs using monopolar, bipolar, or pulsed RF.
Neuromodulation - Boston Scientific
Boston Scientific is pleased to provide an online pre-authorization portal for Spinal Cord Stimulation for more convenient verification and case tracking.
Boston Scientific Presents Key Data at the 2024 North American ...
Multiple prospective and real-world studies from Europe and the United States demonstrated significant and sustained pain relief using the Boston Scientific proprietary FAST Therapy, designed to provide immediate paresthesia-free pain relief.
Four things to know about our acquisition of ... - Boston Scientific
Feb 29, 2024 · As president of the Neuromodulation business at Boston Scientific, Jim Cassidy and his team around the world are continually seeking to bring new therapies to a wider population of people living with chronic pain.
News Releases - Boston Scientific
This pivotal trial will assess the safety and efficacy of occipital nerve stimulation as a treatment for refractory migraine headache, and will use Boston Scientific's Precision™ neurostimulation system to treat migraine patients who do not respond to other available therapies, or who cannot tolerate the side effects of existing medications.
Boston Scientific: Chronic Pain and Spinal Cord Stimulation (SCS)
Boston Scientific Neuromodulation is an innovation leader in microelectronic implantable technologies used to treat chronic neuropathic pain.
Boston Scientific launches FAST—a new therapy for spinal cord ...
Sep 10, 2021 · Boston Scientific has announced the European launch of FAST—a new, fast-acting sub-perception therapy that the company says is clinically proven to demonstrate significant and sustained pain relief within minutes—for its WaveWriter Alpha spinal cord stimulator (SCS) systems.
Boston Scientific teases new data from spinal cord stimulation …
Jan 22, 2024 · One-year data from Boston Scientific‘s SOLIS trial demonstrates that its WaveWriter Alpha Spinal Cord Stimulation (SCS) system can reduce pain in chronic pain patients by 50%.
JPM24: Boston Scientific picks up Medtronic’s urology neuromodulation …
Jan 8, 2024 · Boston Scientific will acquire Axonics in a $3.7 billion deal, gaining the developer of neurostimulation therapies for urinary and fecal incontinence.
- Some results have been removed